Ozempic is a prescription medication used to treat type 2 diabetes by regulating blood sugar levels. The active ingredient in Ozempic is semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 receptor agonists are known to cause weight loss by reducing appetite and slowing down the emptying of the stomach [1].

According to GoodRx [2], Ozempic is not specifically approved for weight loss, but it can cause weight loss as a side effect. Clinical trials have shown that Ozempic can lead to an average weight loss of 12 pounds over 26 weeks [3]. However, the weight loss effects of Ozempic may vary from person to person and may not be sustained in the long term.

Forbes [4] reports that Ozempic has been approved by the FDA as a weight loss medication under the brand name Wegovy. Wegovy is a higher dose of semaglutide than what is used in Ozempic, and it is specifically indicated for chronic weight management in adults with obesity or overweight with at least one weight-related condition. In clinical trials, Wegovy has been shown to cause significant weight loss and improve overall health outcomes [4].

In conclusion, Ozempic can cause weight loss as a side effect, but it is not specifically approved for weight loss. The weight loss effects of Ozempic may vary from person to person and may not be sustained in the long term. However, a higher dose of semaglutide, under the brand name Wegovy, has been approved by the FDA as a weight loss medication and has shown significant weight loss effects in clinical trials.

Sources:
[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170695/
[2] https://www.goodrx.com/ozempic/ozempic-for-weight-loss
[3] https://www.drugpatentwatch.com/p/tradename/OZEMPIC
[4] https://www.forbes.com/health/body/ozempic-for-weight-loss/